Apotex's $932 million IPO, priced at the top of the range, reflects strong demand for Canadian pharmaceutical stocks and could boost the…
Parabilis completes $745 million US IPO, indicating robust biotech investor appetite and potential gains for biotech ETFs.
JPMorgan advises investors to capitalize on stock market dips, forecasting short-lived pullbacks as strong economic fundamentals and earnings persist.
Saudi contractor MGC postpones its $799 million IPO on the Riyadh exchange, raising concerns about Gulf market sentiment and the outlook for…
Apple's new AI platform debut leaves Wall Street unimpressed, sending shares lower amid doubts over the tech giant's competitive edge in artificial…
Equity markets came under dual pressure from a rout in artificial intelligence stocks and spiking oil prices, threatening to derail the recent…
Carlsberg is set to file for a $700 million IPO of its Indian unit, tapping into the country's booming capital markets.
Goldman Sachs analyst Moe sees a rebound in Korean stocks after a 'scary' correction, as valuations become compelling and governance reforms support…
Goldman Sachs strategist John Flood tells clients the stock market selloff is a buying opportunity, citing strong corporate earnings and economic resilience,…
The S&P 500's longest winning streak in decades is in peril after a sharp selloff in technology stocks, driven by an AI…
JPMorgan's decision to replace its bearish Tesla analyst with a bullish one drives an upgrade in outlook for the electric vehicle stock,…
A much stronger-than-expected US employment report for May fueled bets on aggressive Fed tightening, lifting the dollar and bond yields while weighing…